Exagen Inc. provided revenue guidance for the full year 2022. For the period, the company expects revenue to be in the range of $51 million to $53 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 USD | -1.45% | -1.83% | -31.66% |
Apr. 26 | Exagen Inc. Announces Changes in Board of Directors | CI |
Mar. 18 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.66% | 23.6M | |
+16.17% | 82.36B | |
-29.41% | 69.97B | |
+10.99% | 29.41B | |
-11.35% | 16.99B | |
+0.61% | 17.08B | |
-0.68% | 15.21B | |
+1.32% | 11.84B | |
+3.44% | 13.25B | |
+31.43% | 12.08B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc. Provides Revenue Guidance for the Full Year 2022